Opendata, web and dolomites

RECORDER

Rare Earth based Upconversion Luminescent Nanomaterials as novel bioprobes for the detection of cardiac biomarkers

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 RECORDER project word cloud

Explore the words cloud of the RECORDER project. It provides you a very rough idea of what is the project "RECORDER" about.

900    technologies    leads    patient    acceptor    uc    fluorescence    efficient    sensor    transfer    countries    mb    biomarkers    acid    detection    investigation    nanoparticle    recorder    causes    cvd    sensitive    incapable    give    diseases    underpinning    reported    health    binding    confidence    ami    fabp    phospholipase    specificity    autofluorescence    demands    troponin    ctni    deaths    biophotonic    care    poc    small    upconversion    detect    excited    re    hospitals    conventional    primary    heart    fatty    nature    nm    methodology    longer    rare    speed    resonance    ultraviolet    noise    diagnosis    concentrations    wavelengths    mainly    earth    india    infarction    asian    cardiovascular    absorptions    simultaneous    revolutionize    myocardial    stroke    measureable    point    overcome    doped    gt    lipoprotein    fret    platform    excitation    energy    premature    multiple    infrared    acute    myoglobin    01ng    pla2    laser    biomarker    ml    sensitivity    manner    protein    accurate    visible    lp    dysfunction    cardiac    unambiguous    signal    nanoparticles   

Project "RECORDER" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF LEEDS 

Organization address
address: WOODHOUSE LANE
city: LEEDS
postcode: LS2 9JT
website: www.leeds.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 195˙454 €
 EC max contribution 195˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-07-13   to  2018-08-25

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF LEEDS UK (LEEDS) coordinator 195˙454.00

Map

 Project objective

Cardiovascular diseases (CVD) which include acute myocardial infarction (AMI) and stroke are the main causes of premature deaths in the EU and in Asian countries including India. Researchers have identified and reported that biomarkers can provide advance information about cardiac dysfunction which leads to acute myocardial infarction (AMI) and stroke. However technologies for sensitive and accurate detection of CVD biomarkers are not available. The nature of the CVD also demands efficient simultaneous detection of these biomarkers that the current approaches are incapable of. RECORDER aims to develop a novel biophotonic sensor methodology and technology concept for unambiguous detection of multiple biomarkers, which give confidence in the early diagnosis of CVD that in the longer term can be developed for point of care (POC) applications. The underpinning sensor principle in RECORDER is based on measureable fluorescence resonance energy transfer (FRET) from rare earth (RE) doped nanoparticles under infrared laser (wavelengths >900 nm) excitation known as upconversion fluorescence to acceptor nanoparticle with specific absorptions in the presence of very small concentrations (1-0.01ng/mL) of biomarkers. The investigation of parameters including sensitivity, specificity and speed of detection of CVD biomarkers such as cardiac troponin (mainly, cTnI), heart fatty acid binding protein (H-FABP) lipoprotein-associated phospholipase A(2) (Lp-PLA2) and myoglobin (Mb) based on upconversion and upconversion fluorescence energy transfer (UC-FRET) to overcome large noise in signal due to autofluorescence if excited with ultraviolet or visible wavelengths as in conventional FRET, will be a highly novel approach. UC-FRET applied to detect CVD biomarkers in this project will lead to a novel platform technology that will revolutionize biomarker analysis in a cost effective manner for better patient management in hospitals, primary health care and in the long term at POC.

 Publications

year authors and title journal last update
List of publications.
2018 Padmaja Parameswaran Nampi, Alexandre Vakurov, Lewis E. Mackenzie, Nigel S. Scrutton, Paul A. Millner, Gin Jose, Sikha Saha
Selective cellular imaging with lanthanide based upconversion nanoparticles
published pages: e201800256, ISSN: 1864-063X, DOI: 10.1002/jbio.201800256
Journal of Biophotonics 2019-04-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "RECORDER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "RECORDER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

NSTree (2020)

Understanding substrate delivery for cell wall biosynthesis in plants

Read More  

MetEpiC (2020)

P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis

Read More  

RipGEESE (2020)

Identifying the ripples of gene regulation evolution in the evolution of gene sequences to determine when animal nervous systems evolved

Read More